Search keyWord :

YolTech Therapeutics Announces Positive Clinical Data for YOLT-203, an In Vivo Gene Editing Therapy for Primary Hyperoxaluria Type 1 (PH1)

Feb 26, 2025

SHANGHAI,Feb. 25,2025-- YolTech Therapeutics,a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines,today reported positive results fr

Lessons from Japan's AMR Response for the Global Community

Feb 26, 2025

https://iris.who.int/handle/10665/380481 TOKYO,Feb. 25,2025-- World Health Organization (WHO) Regional Office for the Western Pacific (WPRO) has released Japan\'s AMR Response 2013–2025 alongside Tok

China committed to acting as an 'enabler'

Feb 26, 2025

BEIJING,Feb. 25,2025-- A report from People\'s Daily: Recently,a foreign scholar described China as an "enabler." This term vividly encapsulates China\'s commitment to building a community w

G-P Expands Availability of G-P Gia™; Welcomes Leaders to the Next Era of HR

Feb 26, 2025

The smartest AI global HR advisor,G-P Gia,thinks like a lawyer and cuts the cost and time of compliance by up to 95%; reducing the need to outsource legal in 50 countries and 50 U.S. states

DXC tapped by Skanska to Modernize Global IT Infrastructure

Feb 26, 2025

ASHBURN,VA,Feb. 25,2025-- DXC Technology,(NYSE: DXC),a leading Fortune 500 global technology services provider,has signed an agreement with Skanska AB,a multinational construction and project developm

Flexport Unveils 20+ Tech and AI-Powered Products to Modernize Global Supply Chains

Feb 26, 2025

At the forefront of the launch are Flexport Intelligence with an AI Insights Builder, and Flexport Control Tower expanding supply chain visibility and management capabilities.

India's Bharti Airtel partners Ericsson 5G Core technology to drive 5G evolution

Feb 26, 2025

New agreement spans packet core,signaling,charging & policy solutions STOCKHOLM,Feb. 25,2025-- India\'s Bharti Airtel and Ericsson (NASDAQ: ERIC) have strengthened their longstanding partnership t

BioCity Announces its selective Endothelin Type-A Receptor Antagonist, SC0062, Met the Primary Endpoint in Diabetic Kidney Disease (DKD) in a Phase 2 trial (2-SUCCEED)

Feb 26, 2025

SHANGHAI,Feb. 23,2025-- BioCityBiopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist,SC0062,met the 12-week primary endpoint of a reduction in proteinuria in the

IIIF150 Unveils Latest Flagship Raptor 5G at MWC2025

Feb 26, 2025

BARCELONA,Spain,Feb. 25,2025-- IIIF150,the imaginative ultra-thin rugged phone manufacture,announced their new flagship Raptor 5G which will be showcased in Barcelona,and different tests onsite to cha

How 51Talk is Redefining Online Education Through AI--from the Boardroom to the Classroom

Feb 26, 2025

SINGAPORE,Feb. 25,2025--51Talk,an online English language education platform,has announced plans to launch a comprehensive,AI-powered systems upgrade across its business operations within the coming m

1 ... 248 249 250 251 252 253 254 ... 1285